134 related articles for article (PubMed ID: 38651061)
1. Bioinformatics analysis and experimental verification of TIGD1 in non-small cell lung cancer.
Xia L; Yang Z; Xv M; Wang G; Mao Y; Yang Y; Tang J
Front Med (Lausanne); 2024; 11():1374260. PubMed ID: 38651061
[TBL] [Abstract][Full Text] [Related]
2.
Zou J; Zhang H; Wu Z; Hu W; Zhang T; Xie H; Huang Y; Zhou H
Cancer Biother Radiopharm; 2024 Apr; 39(3):223-235. PubMed ID: 36508261
[No Abstract] [Full Text] [Related]
3. TIGD1, a gene of unknown function, involves cell-cycle progression and correlates with poor prognosis in human cancer.
Yin L; Yan J; Wang Y; Sun Q
J Cell Biochem; 2019 Jun; 120(6):9758-9767. PubMed ID: 30548305
[TBL] [Abstract][Full Text] [Related]
4. A novel oncogene trigger transposable element derived-1 promotes oral squamous cell carcinoma progression via evoking immune inhibition.
Qiao X; Zhu L; Song R; Shang C; Guo Y
Mol Carcinog; 2023 Aug; 62(8):1213-1227. PubMed ID: 37144838
[TBL] [Abstract][Full Text] [Related]
5. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
6. Glycogen phosphorylase B promotes cell proliferation and migration through PI3K/AKT pathway in non-small cell lung cancer.
Zhan Y; Chen R; Wang T; Shan S; Zhu H
Exp Lung Res; 2021 Apr; 47(3):111-120. PubMed ID: 33336613
[TBL] [Abstract][Full Text] [Related]
7. LAGE3 promotes cell metastasis and stemness in non-small cell lung cancer companied with AKT/PI3K signaling pathway activation.
Zhang H; Jian J; Chen H; Zhu X; Xie J; Xu X
Pathol Res Pract; 2023 Aug; 248():154700. PubMed ID: 37473499
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
9. SIRT6 through PI3K/Akt/mTOR signaling pathway to enhance radiosensitivity of non-Small cell lung cancer and inhibit tumor progression.
Xiong L; Tan B; Lei X; Zhang B; Li W; Liu D; Xia T
IUBMB Life; 2021 Sep; 73(9):1092-1102. PubMed ID: 34033225
[TBL] [Abstract][Full Text] [Related]
10. Berberine targets KIF20A and CCNE2 to inhibit the progression of nonsmall cell lung cancer via the PI3K/AKT pathway.
Wang Q; Wu H; Wu Q; Zhong S
Drug Dev Res; 2023 Aug; 84(5):907-921. PubMed ID: 37070571
[TBL] [Abstract][Full Text] [Related]
11. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways.
Jiang M; Zhou LY; Xu N; An Q
Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884
[TBL] [Abstract][Full Text] [Related]
12. Tastin promotes non-small-cell lung cancer progression through the ErbB4, PI3K/AKT, and ERK1/2 pathways.
Yue A; Chen M; Dai S; Zhang Y; Wei W; Fan L; Wang F; Zhang F; Yu H; Lu Y; Lei Y
Exp Biol Med (Maywood); 2023 Mar; 248(6):519-531. PubMed ID: 36691332
[TBL] [Abstract][Full Text] [Related]
13. TTI1 promotes non-small-cell lung cancer progression by regulating the mTOR signaling pathway.
Zhang LX; Yang X; Wu ZB; Liao ZM; Wang DG; Chen SW; Lu F; Wu YB; Zhu SQ
Cancer Sci; 2023 Mar; 114(3):855-869. PubMed ID: 36403197
[TBL] [Abstract][Full Text] [Related]
14. Effect of AGER on the biological behavior of non‑small cell lung cancer H1299 cells.
Wang Q; Zhu W; Xiao G; Ding M; Chang J; Liao H
Mol Med Rep; 2020 Aug; 22(2):810-818. PubMed ID: 32468030
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics identification of miR-514b-5p promotes NSCLC progression and induces PI3K/AKT and p38 pathways by targeting small glutamine-rich tetratricopeptide repeat-containing protein beta.
Shi L; Kan J; Zhuo L; Wang S; Chen S; Zhang B; Ke B
FEBS J; 2023 Feb; 290(4):1134-1150. PubMed ID: 36180981
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of ADAMDEC1 correlates with tumor progression and predicts poor prognosis in non-small cell lung cancer (NSCLC) via the PI3K/AKT pathway.
Zhu W; Shi L; Gong Y; Zhuo L; Wang S; Chen S; Zhang B; Ke B
Thorac Cancer; 2022 Apr; 13(7):1027-1039. PubMed ID: 35178875
[TBL] [Abstract][Full Text] [Related]
17. Autocrined leptin promotes proliferation of non-small cell lung cancer (NSCLC) via
Wang J; Zhou F; Li F; Wang B; Hu Y; Li X
Ann Transl Med; 2021 Apr; 9(7):568. PubMed ID: 33987266
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA‑373‑3p inhibits the proliferation and invasion of non‑small‑cell lung cancer cells by targeting the GAB2/PI3K/AKT pathway.
Zhu X; Chen X; Zhang X; Zhao L; Shen X
Oncol Lett; 2024 May; 27(5):221. PubMed ID: 38586211
[TBL] [Abstract][Full Text] [Related]
19. Targeting DNAJC19 overcomes tumor growth and lung metastasis in NSCLC by regulating PI3K/AKT signaling.
Zhou J; Peng Y; Gao YC; Chen TY; Li PC; Xu K; Liu T; Ren T
Cancer Cell Int; 2021 Jul; 21(1):338. PubMed ID: 34217321
[TBL] [Abstract][Full Text] [Related]
20. METTL3 regulatory TROAP can regulate the progression of non-small cell lung cancer through PI3K/AKT and EMT signaling pathway.
Xu M; Yu J; Liu X; Jia W; Duan Y; Ma D; Ma J; Lei W; Tai W
Med Oncol; 2023 Aug; 40(9):274. PubMed ID: 37608033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
